Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic

NCT04442282 | Unknown DMC

• 1 other identifier: REK125510 (5)
• Study Type: observational
• Target: 5,041
• Locations: 0 countries
• Sites: N/A

Brief Summary

Central indicators of psychological functioning such as difficulties in emotion regulation and habitual problems in one's relating to others are likely to have been substantially impacted by the COVID-19 amelioration measures of societal lock-down and physical (ne social) distancing. In turn, as these amelioration measures have been relaxed, that impact will presumably be reduced, gradually returning these factors to pre-crisis levels. Also, these factors are likely to predict mental health outcomes such as symptoms of depression and anxiety throughout the pandemic and beyond, so that levels of emotion regulation difficulties and interpersonal problems early on will predict later symptom status. Similarly reductions in such difficulties during the various phases of the outbreak will be associated with a concurrent reduction in psychological symptoms and reduced symptom levels at later stages.

Conditions

Anxiety; Depression; Interpersonal Problem; Emotion Regulation

Outcome Measures

Primary Outcomes (4)

• Patient Health Questionnaire 9 (PHQ-9)

  The Patient Health Questionnaire 9 (PHQ-9; Kroenke, Spitzer \& Williams, 2001) is used to measure symptoms of depression in accordance with the diagnostic criteria for major depressive disorder. The questionnaire consists of nine items where each is scored on a four-point Likert scale (0-3), with the range of scores from 0 to 27. Higher scores indicate greater depression severity, and scores above 10 are considered as the cut-off that indicating that the patient is within the depressive area.

  Data is set to be collected starting from 22th of June. The data collection period will last no longer than three weeks depending on the response to the questionnaire

• The Generalized Anxiety Disorder - 7

  The Generalized Anxiety Disorder 7 (GAD-7; Spitzer, Kroenke, Williams \& Löwe, 2006) is a questionnaire consisting of seven items measuring symptoms of anxiety and worry. The items are scored on a four-point Likert scale (0-3), with the scores ranging from 0 to 21. Specific cut-off for Norwegian samples have been found yielding a cut-off of 8 and above for high sensitivity and specificity (Johnson, Ulvenes, Øktedalen \& Hoffart, 2019). The Generalized Anxiety Disorder 7 (GAD-7; Spitzer, Kroenke, Williams \& Löwe, 2006) is a questionnaire consisting of seven items measuring symptoms of anxiety and worry. The items are scored on a four-point Likert scale (0-3), with the scores ranging from 0 to 21. Specific cut-off for Norwegian samples have been found yielding a cut-off of 8 and above for high sensitivity and specificity (Johnson, Ulvenes, Øktedalen \& Hoffart, 2019).

  Data is set to be collected starting from 22th of June. The data collection period will last no longer than three weeks depending on the response to the questionnaire

• Difficulties in Emotion Regulation Scale

  6 items from DERS (Gratz \& Roemer, 2004)

  Data is set to be collected starting from 22th of June. The data collection period will last no longer than three weeks depending on the response to the questionnaire

• Interpersonal problems

  17 Items from IIP-64 (Horowitz et al. 2000)

  Data is set to be collected starting from 22th of June. The data collection period will last no longer than three weeks depending on the response to the questionnaire

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

General population in Norway.

You may qualify if:

• Eligible participants are all adults including those of 18 years and above,
• Who are currently living in Norway and thus experiencing identical NPIs, and
• Who provide digital consent to partake in the study.

You may not qualify if:

• Children and adolescents (individuals below 18)
• Adults not residing in Norway during the measurement period

Sponsors & Collaborators

• University of Oslo: lead
• Modum Bad: collaborator

MeSH Terms

Conditions

Anxiety Disorders; Depression; Emotional Regulation

Condition Hierarchy (Ancestors)

Mental Disorders; Behavioral Symptoms; Behavior; Self-Control; Social Behavior

Study Officials

• Ole Andrè Solbakken, PhD

  University of Oslo

  PRINCIPAL INVESTIGATOR

• Jon Monsen, PhD

  University of Oslo

  PRINCIPAL INVESTIGATOR

• Asle Hoffart, PhD

  University of Oslo & Modum Bad

  PRINCIPAL INVESTIGATOR

• Omid Ebrahimi, Mr

  University of Oslo & Modum Bad

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Sverre Urnes Johnson, PhD

CONTACT

41633313; s.u.johnson@psykologi.uio.no

Omid Ebrahimi, Mr

CONTACT

omideb@uio.no

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professer Sverre Urnes Johnson

Study Record Dates

• First Submitted: June 19, 2020
• First Posted: June 22, 2020
• Study Start: June 22, 2020
• Primary Completion: July 13, 2020
• Study Completion: July 13, 2020
• Last Updated: June 22, 2020

Record last verified: 2020-06

Data Sharing

• IPD Sharing: Will not share